Free access

Lung histopathology evaluation of an X-MAID patient with a novel mutation in MSN

Publication: LymphoSign Journal
29 March 2023

Abstract

Background: The cell cytoskeleton is regulated by the ezrin-radixin-moesin (ERM) family of proteins, forming links between transmembrane proteins and the underlying actin cytoskeleton. Phosphorylation and activation of these proteins enable interactions with partners critically involved in shape regulation, such as actin filaments, transmembrane proteins, and scaffolding proteins. The MSN gene encodes moesin, which is ubiquitously expressed in lungs, spleen, kidney, endothelial cells of vessels, lymphocytes, and neutrophils. Deficiency or dysregulation of moesin, called X-linked moesin-associated immunodeficiency (X-MAID), is characterized by severe leukopenia affecting T cells, B cells, and neutrophils. To date, the clinical picture of patients with X-MAID is variable.
Aim: We describe the presentation, immune-workup, and lung histopathology findings of a young male patient with X-MAID and multi-organ involvement, whose severe pulmonary vein stenosis necessitated a double lung transplant.
Methods: A thorough review of the patient’s chart was performed.
Results: The patient presented with a history of recurrent respiratory tract infections, oral thrush, and 3 major bacterial infections requiring admission and antibiotic therapy. His immune evaluation was remarkable for low T cells, and normal numbers of B and NK cells. At age 4 years he underwent a double lung transplant due to severe pulmonary vein stenosis and pulmonary hypertension. He further developed chronic kidney injury post-transplant. Clinical trio whole exome sequencing revealed a novel hemizygous variant in the MSN gene (c.278dupT; p.L93FfsX21), predicted to cause loss-of-function in moesin. Histologic evaluation of the lung tissue before transplantation identified profound abnormalities in alveoli formation.
Conclusion: Patients with moesin deficiency may present during infancy or childhood with a severe form of the disease, including combined immunodeficiency with lymphopenia and neutropenia, while adults may have a milder clinical picture. The novel MSN mutation described here adds to the known spectrum of disease and highlights the non-redundant functions of moesin, particularly in the lung.
Statement of Novelty: We report the first lung histopathological description of an X-MAID case, in a pediatric patient with recurrent infections, cytopenia, and autoimmunity who underwent a double lung transplant.

Formats available

You can view the full content in the following formats:

REFERENCES

Bradshaw G., Lualhati R.R., Albury C.L., Maksemous N., Roos-Araujo D., Smith R.A., Benton M.C., Eccles D.A., Lea R.A., Sutherland H.G., Haupt L.M., and Griffiths L.R. 2018. Exome sequencing diagnoses X-linked moesin-associated immunodeficiency in a primary immunodeficiency case. Front Immunol 9: 420.
Delmonte O.M., Biggs C.M., Hayward A., Comeau A.M., Kuehn H.S., Rosenzweig S.D., and Notarangelo L.D. 2017. First case of X-Linked Moesin deficiency identified after newborn screening for SCID. J. Clin. Immunol. 37(4): 336–338.
Dvorak C.C., Haddad E., Buckley R.H., Cowan M.J., Logan B., Griffith L.M., Kohn D.B., Pai S.-Y., Notarangelo L., Shearer W., Prockop S., Kapoor N., Heimall J., Chaudhury S., Shyr D., Chandra S., Cuvelier G., Moore T., Shenoy S., Goldman F., Smith A.R., Sunkersett G., Lugt M.V., Caywood E., Quigg T., Torgerson T., Chandrakasan S., Craddock J., Saldaña B.J.D., Gillio A., Shereck E., Aquino V., DeSantes K., Knutsen A., Thakar M., Yu L., and Puck J.M. 2019. The genetic landscape of severe combined immunodeficiency in the United States and Canada in the current era (2010-2018). J. Allergy Clin. Immunol. 143(1): 405–407.
Fehon R.G., McClatchey A.I., and Bretscher A. 2010. Organizing the cell cortex: The role of ERM proteins. Nat. Rev. Mol. Cell Biol. 11(4): 276–287.
García-Ortiz A. and Serrador J.M. 2020. Erm proteins at the crossroad of leukocyte polarization, migration and intercellular adhesion. Int. J. Mol. Sci. 21(4): 1502.
Hashimoto S., Amaya F., Matsuyama H., Ueno H., Kikuchi S., Tanaka M., Watanabe Y., Ebina M., Ishizaka A., Tsukita S., and Hashimoto S. 2008. Dysregulation of lung injury and repair in moesin-deficient mice treated with intratracheal bleomycin. Am. J. Physiol. Lung. Cell. Mol. Physiol. 295: 566–574.
Henrickson S.E., Andre-Schmutz I., Lagresle-Peyrou C., Deardorff M., Jyonouchi H., Neven B., Bunin N., and Heimall J. 2019. Hematopoietic stem cell transplant for the treatment of X-MAID. Front. Pediatr. 7: 170.
Kawaguchi K., Yoshida S., Hatano R., and Asano S. 2017. Pathophysiological Roles of Ezrin/Radixin/Moesin Proteins. Biol. Pharm. Bull. 40(4): 381–390.
Kovács A.L., Kárteszi J., Prohászka Z., Kalmár T., Késmárky G., Koltai K., Nagy Z., Sebők J., Vas T., Molnár K., Berki T., Böröcz K., Gyömörei C., Szalma J., Egyed M., Horváth S., Oláh P., Csuka D., Németh V., and Gyulai R. 2022. Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50. Front. Immunol. 13: 919411.
Lagresle-Peyrou C., Luce S., Ouchani F., Soheili T.S., Sadek H., Chouteau M., Durand A., Pic I., Majewski J., Brouzes C., Lambert N., Bohineust A., Verhoeyen E., Cosset F.L., Magerus-Chatinet A., Rieux-Laucat F., Gandemer V., Monnier D., Heijmans C., van Gijn M., Dalm V.A., Mahlaoui N., Stephan J.-L., Picard C., Durandy A., Kracker S., Hivroz C., Jabado N., Basile G.de S., Fischer A., Cavazzana M., and André-Schmutz I. 2016. X-linked primary immunodeficiency associated with hemizygous mutations in the moesin (MSN) gene. J. Allergy Clin. Immunol. 138(6): 1681–1689.e8.
Liu X., Yang T., Suzuki K., Tsukita S., Ishii M., Zhou S., Wang G., Cao L., Qian F., Taylor S., Oh M.J., Levitan I., Ye R.D., Carnegie G.K., Zhao Y., Malik A.B., and Xu J. 2015. Moesin and myosin phosphatase confine neutrophil orientation in a chemotactic gradient. J. Exp. Med. 212(2): 267–280.
Michie K.A., Bermeister A., Robertson N.O., Goodchild S.C., and Curmi P.M.G. 2019. Two Sides of the Coin: Ezrin/Radixin/Moesin and merlin control membrane structure and contact inhibition. Int. J. Mol. Sci. 20(8): 1996.
Niggli V. and Rossy J. 2008. Ezrin/radixin/moesin: Versatile controllers of signaling molecules and of the cortical cytoskeleton. Int. J. Biochem. Cell Biol. 40(3): 344–349.
Sprenkeler E.G.G., Webbers S.D.S., and Kuijpers T.W. 2021. When Actin is Not Actin’ like It should: A new category of distinct primary immunodeficiency disorders. J. Innate. Immun. 13(1): 3–25.

Information & Authors

Information

Published In

cover image LymphoSign Journal
LymphoSign Journal
Volume 10Number 1March 2023
Pages: 1 - 6

History

Received: 23 March 2023
Accepted: 27 March 2023
Accepted manuscript online: 29 March 2023
Version of record online: 29 March 2023

Authors

Affiliations

Laura Abrego Fuentes
Division of Immunology & Allergy, Department of Pediatrics, Hospital for Sick Children and University of Toronto, Toronto, ON
Amarilla B. Mandola
Edmund and Lilly Safra Children’s Hospital, Sheba Medical Centre, Pediatric Department A and Immunology Service, Tel Hashomer, Israel; Clinical Immunology, Angioedema and Allergy Unit, Center for Autoimmune Diseases, Sheba Medical Center, Tel Hashomer, Israel; The Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
Department of Paediatric Laboratory Medicine, Hospital for Sick Children, Toronto, ON

Metrics & Citations

Metrics

Other Metrics

Citations

Cite As

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

There are no citations for this item

View Options

View options

PDF

View PDF

Full Text

View Full Text

Get Access

Media

Media

Other

Tables

Share Options

Share

Share the article link

Share on social media